Exelixis
EXEL
#1790
Rank
NZ$19.24 B
Marketcap
NZ$71.50
Share price
1.22%
Change (1 day)
14.39%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company